Description
This session will provide an overview of the current trends in pulmonary exacerbation management highlighting the pros and cons of home versus hospital exacerbation treatment. In addition, models for both inpatient and outpatient exacerbation management from onset to resolution will be discussed.
Learning Objectives:
- Describe the benefits, risks and outcome variation of treating pulmonary exacerbations in the home versus hospital setting, addressing the medical, social and economic implications of each.
- Identify trends of home intravenous management, discussing a model of monitoring, and issues related to delivery devices, safety and drug stability.
- Review the importance of following exacerbation to resolution and present a sample algorithm of standardized exacerbation identification and treatment.
Symposium Chair(s):
Symposium Speaker(s):
- Debbie
Benitez,
ACNP-BC,
NP/Coordinator
- Alex
Burchill,
Pharm.D.,
Clinical Pharmacist
- Elliott
Dasenbrook,
M.D., M.H.S.,
Staff Physician
- Don
Sanders,
M.D., M.S.,
Associate Professor
- Joshua
Wang,
Pharm.D.,
Pharmacist
